Advertisement

ReShape Lifesciences Inc. RSLS

Set alert

Price alert · RSLS

All alert types
3.92 0.00 0.00%

At close · Aug 14

2.80 Day range 4.65
4.09 52-week range 29.00
YTD
-99.12%
1 year
-99.62%
Open
3.06
Prev close
3.92
Mkt cap
3.04M
Vol
13.59M
Avg vol
113.58K
EPS
77.26
P/E
0.06
Div yield
0.00%
More statistics
Low
2.80
High
4.65
Forward P/E
-11.83
Beta
1.35
Short ratio
0.22
Inst. own
1.83%
Dividend
0.00
Ex-div date
50-d avg
5.39
200-d avg
9.00
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for RSLS has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $174.40KExpenses → Selling, General & Admin: $364.89KExpenses → Research & Development: $506.72KGross Profit → Expenses: $11.66KRevenue → Gross Profit: $11.66KRevenue → Cost of Revenue: $15.30KNet Loss → Expenses: $685.56KOther Income$174.40KGross Profit$11.66KNet Loss$685.56KCost of Revenue$15.30KExpenses$871.61KSelling, General & Admin$364.89KResearch & Development$506.72KRevenue$26.95K

Period ending Jun 30, 2025 · select a line to chart its history

Income statement

RSLS quarterly income statement
1.24M
1.24M
643.00K
599.00K
3.36M
476.00K
2.17M
-2.76M
-18.00K
8.00K
-2.63M
-2.63M
-2.63M
-2.63M
-2.25
-2.25
-2.25
-2.64M
-2.64M
1.17M
1.17M

Balance sheet

RSLS quarterly balance sheet
4.22M
4.22M
605.00K
605.00K
775.00K
8.86M
109.00K
9.03M
104.00K
104.00K
3.20M
3.20M
-643.86M
-109.00K
5.83M
5.83M
166.00K
104.00K
2.55M
1.35M
28.00K

Cash flow

RSLS quarterly cash flow
4.00K
6.10M
1.61M
6.10M
-4.49M
1.00K
12.00K
Advertisement